https://www.selleckchem.com/pr....oducts/1-phenyl-2-th
5 years of follow-up (75% of subjects) showed a 15% increased mortality when compared to MOHR ( .01); however, after 3.5 years, no difference in survival was noted ( = .5). Patients with HNM showed a higher mortality when compared to MOR. The risk of death of primary sites within the head and neck varies over time, showing a higher risk of mortality for scalp and neck during the first 3.5 years of follow-up. This increased risk was not evident after the 3.5-year threshold. Further research is needed to evaluate addition
Like
Comment
Share
